Sulfated oxysterol, 25HC3S, is a potent regulator of lipid metabolism in human hepatocytes

Biochemical and Biophysical Research Communications

Volumn 360, Issue 4, 2007, Pages 802-808

  Ren, Shunlin ^a   Li, Xiaobo ^a,b   Rodriguez Agudo, Daniel ^a   Gil, Gregorio ^b   Hylemon, Phillip ^b   Pandak, William M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

25 Diol 3 sulfate; 5 Cholesten 3 ; Acetyl CoA carboxylase 1; Bile acid synthesis; Cholesterol and lipids metabolism; Fatty acid synthase; HMG CoA reductase; Mitochondria; SREBPs

Indexed keywords

5 CHOLESTEN 3BETA, 25 DIOL 3 SULFATE; ACETYL COENZYME A CARBOXYLASE; FATTY ACID SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MESSENGER RNA; STEROL DERIVATIVE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID METABOLISM; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; DNA PRIMERS; HEPATOCYTES; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPID METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROLS; SULFATES;

RATTUS;

EID: 34447566893     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.143     Document Type: Article

References (39)

1. Vlahcevic Z.R., Jairath S.K., Heuman D.M., Stravitz R.T., Hylemon P.B., Avadhani N.G., and Pandak W.M. Transcriptional regulation of hepatic sterol 27-hydroxylase by bile acids. Am. J. Physiol. 270 (1996) G646-G652
2. Dubrac S., Lear S.R., Ananthanarayanan M., Balasubramaniyan N., Bollineni J., Shefer S., Hyogo H., Cohen D.E., Blanche P.J., Krauss R.M., et al. Role of CYP27A in cholesterol and bile acid metabolism. J. Lipid Res. 46 (2005) 76-85
3. Adams C.M., Reitz J., De Brabander J.K., Feramisco J.D., Li L., Brown M.S., and Goldstein J.L. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J. Biol. Chem. 279 (2004) 52772-52780
4. Babiker A., Andersson O., Lund E., Xiu R.J., Deeb S., Reshef A., Leitersdorf E., Diczfalusy U., and Bjorkhem I. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem. 272 (1997) 26253-26261
5. Bjorkhem I. Do oxysterols control cholesterol homeostasis?. J. Clin. Invest 110 (2002) 725-730
6. Fu X., Menke J.G., Chen Y., Zhou G., Macnaul K.L., Wright S.D., Sparrow C.P., and Lund E.G. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276 (2001) 38378-38387
7. Meir K., Kitsberg D., Alkalay I., Szafer F., Rosen H., Shpitzen S., Avi L.B., Staels B., Fievet C., Meiner V., et al. Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. J. Biol. Chem. 277 (2002) 34036-34041
8. Li X., Hylemon P., Pandak W.M., and Ren S. Enzyme activity assay for cholesterol 27-hydroxylase in mitochondria. J. Lipid Res. 47 (2006) 1507-1512
9. Bjorkhem I., and Diczfalusy U. Oxysterols: friends, foes, or just fellow passengers?. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 734-742
10. Corsini A., Verri D., Raiteri M., Quarato P., Paoletti R., and Fumagalli R. Effects of 26-aminocholesterol, 27-hydroxycholesterol, and 25-hydroxycholesterol on proliferation and cholesterol homeostasis in arterial myocytes. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 420-428
11. Pandak W.M., Ren S., Marques D., Hall E., Redford K., Mallonee D., Bohdan P., Heuman D., Gil G., and Hylemon P. Transport of cholesterol into mitochondria is rate-limiting for bile acid synthesis via the alternative pathway in primary rat hepatocytes. J. Biol. Chem. 277 (2002) 48158-48164
12. Ren S., Hylemon P.B., Marques D., Gurley E., Bodhan P., Hall E., Redford K., Gil G., and Pandak W.M. Overexpression of cholesterol transporter StAR increases in vivo rates of bile acid synthesis in the rat and mouse. Hepatology 40 (2004) 910-917
13. Hall E.A., Ren S., Hylemon P.B., Rodriguez-Agudo D., Redford K., Marques D., Kang D., Gil G., and Pandak W.M. Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells. Biochim. Biophys. Acta 1733 (2005) 111-119
14. Ren S., Hylemon P., Zhang Z.P., Rodriguez-Agudo D., Marques D., Li X., Zhou H., Gil G., and Pandak W.M. Identification of a novel sulfonated oxysterol, 5-cholesten-3beta,25-diol 3-sulfonate, in hepatocyte nuclei and mitochondria. J. Lipid Res. 47 (2006) 1081-1090
15. Chen W., Chen G., Hea D.L., Mangelsdor D.J., and Russell D.W. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab. 5 (2007) 73-79
16. Rodriguez-Agudo D., Ren S., Hylemon P.B., Redford K., Natarajan R., Del Castillo A., Gil G., and Pandak W.M. Human StarD5, a cytosolic StAR-related lipid binding protein. J. Lipid Res. 46 (2005) 1615-1623
17. Dusza J.P., Joseph J.P., and Bernstein S. The preparation of estradiol-17 beta sulfates with triethylamine-sulfur trioxide. Steroids 45 (1985) 303-315
18. Ren S., Scarsdale J.N., Ariga T., Zhang Y., Klein R.A., Hartmann R., Kushi Y., Egge H., and Yu R.K. O-Acetylated gangliosides in bovine buttermilk. Characterization of 7-O-acetyl, 9-O-acetyl, and 7,9-di-O-acetyl GD3. J. Biol. Chem. 267 (1992) 12632-12638
19. Ren S., Hylemon P., Marques D., Hall E., Redford K., Gil G., and Pandak W.M. Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis. J. Lipid Res. 45 (2004) 2123-2131
20. Hall E., Hylemon P., Vlahcevic Z., Mallonee D., Valerie K., Avadhani N., and Pandak W. Overexpression of CYP27 in hepatic and extrahepatic cells: role in the regulation of cholesterol homeostasis. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001) G293-G301
21. Yeh M., Cole A.L., Choi J., Liu Y., Tulchinsky D., Qiao J.H., Fishbein M.C., Dooley A.N., Hovnanian T., Mouilleseaux K., et al. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Circ. Res. 95 (2004) 780-788
22. Zeng L., Liao H., Liu Y., Lee T.S., Zhu M., Wang X., Stemerman M.B., Zhu Y., and Shyy J.Y. Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism. J. Biol. Chem. 279 (2004) 48801-48807
23. Schroepfer Jr. G.J. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev. 80 (2000) 361-554
24. Alberti S., Steffensen K.R., and Gustafsson J.A. Structural characterisation of the mouse nuclear oxysterol receptor genes LXRalpha and LXRbeta. Gene 243 (2000) 93-103
25. Janowski B.A., Willy P.J., Devi T.R., Falck J.R., and Mangelsdorf D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383 (1996) 728-731
26. Janowski B.A., Grogan M.J., Jones S.A., Wisely G.B., Kliewer S.A., Corey E.J., and Mangelsdorf D.J. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. USA 96 (1999) 266-271
27. Landis M.S., Patel H.V., and Capone J.P. Oxysterol activators of liver X receptor and 9-cis-retinoic acid promote sequential steps in the synthesis and secretion of tumor necrosis factor-alpha from human monocytes. J. Biol. Chem. 277 (2002) 4713-4721
28. Malerod L., Juvet L.K., Hanssen-Bauer A., Eskild W., and Berg T. Oxysterol-activated LXRalpha/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Biochem. Biophys. Res. Commun. 299 (2002) 916-923
29. Peet D.J., Janowski B.A., and Mangelsdorf D.J. The LXRs: a new class of oxysterol receptors. Curr. Opin. Genet. Dev. 8 (1998) 571-575
30. Grefhorst A., Elzinga B.M., Voshol P.J., Plosch T., Kok T., Bloks V.W., van der Sluijs F.H., Havekes L.M., Romijn J.A., Verkade H.J., et al. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J. Biol. Chem. 277 (2002) 34182-34190
31. Bocher V., Millatt L.J., Fruchart J.C., and Staels B. Liver X receptors: new players in atherogenesis?. Curr. Opin. Lipidol. 14 (2003) 137-143
32. Horton J.D., Shah N.A., Warrington J.A., Anderson N.N., Park S.W., Brown M.S., and Goldstein J.L. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. USA 100 (2003) 12027-12032
33. Bobard A., Hainault I., Ferre P., Foufelle F., and Bossard P. Differential regulation of SREBP-1c transcriptional activity by insulin and LXR during liver development. J. Biol. Chem. (2004)
34. Botolin D., and Jump D.B. Selective proteolytic processing of rat hepatic sterol regulatory element binding protein-1 (SREBP-1) and SREBP-2 during postnatal development. J. Biol. Chem. 278 (2003) 6959-6962
35. Castillo-Olivares A., and Gil G. Differential effects of sterol regulatory binding proteins 1 and 2 on sterol 12 alpha-hydroxylase. SREBP-2 suppresses the sterol 12 alpha-hydroxylase promoter. J. Biol. Chem. 277 (2002) 6750-6757
36. Dif N., Euthine V., Gonnet E., Laville M., Vidal H., and Lefai E. Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs. Biochem. J. 400 (2006) 179-188
37. Seegmiller A.C., Dobrosotskaya I., Goldstein J.L., Ho Y.K., Brown M.S., and Rawson R.B. The SREBP pathway in Drosophila: regulation by palmitate, not sterols. Dev. Cell 2 (2002) 229-238
38. Wong J., Quinn C.M., and Brown A.J. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem. J. 400 (2006) 485-491
39. Li X., Pandak M.W., Erickson S.K., Hylemon P., and Ren S. A novel metabolic pathway for the synthesis of the newly discovered nuclear 5-cholesten-3beta, 25-diol 3-sulphate. FASEB J. 21 5 (2007) 487.6